Learn more about racial disparities in hereditary cancer clinical trials in this discussion presented by the Basser Center for BRCA’s Black & BRCA initiative. This conversation features Ashley Dedmon, a patient advocate and member of the Basser Young Leadership Council, and Armenta Washington, a Senior Research Coordinator at Penn Medicine’s Community Outreach and Engagement Program.

Basser Center Genetic Counselor Danielle McKenna, MS, LCGC, discusses the recommended age for genetic testing for BRCA1/2 mutations for both men and women.

Basser Center Executive Director Susan Domchek, MD, answers a series of frequently asked questions. She discusses ovarian cancer surveillance, BRCA mutations in the Ashkenazi Jewish community, COVID vaccines, and more.

Learn about one family's journey with BRCA in this discussion between Basser Center Executive Director Susan Domchek, MD, Ali Rogin (author of Beat Breast Cancer Like A Boss) and her parents, Rebecca and Max Weinberg (drummer for the E Street Band).

In the Basser Center's Annual Research Webinar, Executive Director Susan Domchek, MD, covers the latest updates in hereditary cancer care, BRCA research, and genetics, addressing advances in 2020 and exploring options for the future.

Penn Medicine oncologist and Basser Center researcher Vivek Narayan, MD, MS, discusses BRCA-related prostate cancer treatment, recent scientific innovations, and the importance of philanthropy.

Basser Center Executive Director Susan Domchek, MD, discusses what she hopes will be the next advances in BRCA-related research and hereditary cancer care, including liquid biopsies and determining individualized risk.

Basser Center Genetic Counselor Jacquelyn Powers, MS, LCGC, discusses the basic of BRCA mutations in men and shares helpful information like associated cancer risk and typical screening recommendations.

The Basser Center's Young Leadership Council presents a panel on racial health disparities, moderated by women's health advocate Alejandra Campoverdi, with the participation of Basser oncologist Payal Shah, MD, and Basser Young Leadership Council members Ashley Dedmon and Nicole Garcia.

Basser Executive Director Susan, Domchek, MD, discusses BRCA mutations and the ways in which individualized risk for hereditary cancer can be determined.